Growth Metrics

Resmed (RMD) Other Accumulated Expenses (2016 - 2021)

Resmed's Other Accumulated Expenses history spans 12 years, with the latest figure at $12.3 million for Q2 2021.

  • For Q2 2021, Other Accumulated Expenses fell 1.77% year-over-year to $12.3 million; the TTM value through Jun 2021 reached $12.3 million, down 1.77%, while the annual FY2021 figure was $12.3 million, 1.77% down from the prior year.
  • Other Accumulated Expenses reached $12.3 million in Q2 2021 per RMD's latest filing, down from $12.5 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $41.2 million in Q2 2019 to a low of $10.9 million in Q2 2017.
  • Average Other Accumulated Expenses over 5 years is $17.6 million, with a median of $12.3 million recorded in 2021.
  • Peak YoY movement for Other Accumulated Expenses: surged 274.91% in 2019, then plummeted 69.7% in 2020.
  • A 5-year view of Other Accumulated Expenses shows it stood at $10.9 million in 2017, then increased by 0.93% to $11.0 million in 2018, then soared by 274.91% to $41.2 million in 2019, then tumbled by 69.7% to $12.5 million in 2020, then decreased by 1.77% to $12.3 million in 2021.
  • Per Business Quant, the three most recent readings for RMD's Other Accumulated Expenses are $12.3 million (Q2 2021), $12.5 million (Q2 2020), and $41.2 million (Q2 2019).